Seed-implant therapy shows promise for prostate cancer patients.(Originated from Knight-Ridder Newspapers)Poirot, Carolyn
Radioactive seeds are an effective and very exciting therapy for men who are not candidates for surgery or don't want surgery. What that involves is taking tiny little rice-sized pellets, making them radioactive in a very controlled way so it's not wild radiation, it's very controlled, ve...
Radioactive seed implants are a form ofradiation therapyforprostate cancer. Brachytherapy, or internal radiation therapy, are also terms used to describe this procedure. There are two types ofprostatebrachytherapy: permanent and temporary. Compared toexternal radiation, which requires five to eight weeks...
These findings suggest that NLS has potential for development into a safe and potent alternative therapy for prostate cancer patients.doi:10.1038/srep41656Hongwei GuoHua LuoHebao YuanYudui XiaJian ZhangNature Publishing GroupScientific ReportsGuo H, Luo H, Yuan H, Xia Y, Shu P, ...
Purpose: Permanent seed implantation is a well accepted therapy for the treatment of low risk prostate cancer. In Europe the number of treated patients inc... R Baumann,A Warszawski,S Machtens,... - 《Medical Physics》 被引量: 0发表: 2005年 Stereotactic radiotherapy for liver oligometastases...
CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy. The recurrent carcinoma has been difficult to manage after surgery and radiotherapy, extensive resection of locally recurrent rectal cancer is associated w... JJ Wang,SY Hui,NL Jin,... - 《Medical Oncology...
Purpose: Gold seed fiducial markers can be used to accurately define daily treatment field placement for prostate cancer patients. In 2007, a small study was undertaken to evaluate the effectiveness of using gold seed fiducial markers. Methods: Eleven patients who attended for treatment had three ...
Background To evaluate the safety and efficacy of brachytherapy with permanent iodine-125 seed implantation (PI) for prostate cancer. The nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) has continued since July 2005. This manuscript presents the rat...
Blocking androgen receptor signaling is the mainstay of therapy for advanced prostate cancer (PCa). However, acquired resistance to single agents targeting this pathway results in the development of lethal castration-resistant PCa. Combination therapy approaches represent a promising strategy for the ...
To examine the outcome of deferred permanent seed brachytherapy (BT) for localized low or intermediate risk prostate cancer in order to identify predictors of delayed therapy (DT).We studied 714 patients treated with BT with or without external radiotherapy. DT was defined as no treatment for > ...